Literature DB >> 17563743

Mitotic kinase Aurora-A phosphorylates RASSF1A and modulates RASSF1A-mediated microtubule interaction and M-phase cell cycle regulation.

R Rong1, L Y Jiang, M S Sheikh, Y Huang.   

Abstract

RASSF1A (RAS-association domain family 1, isoform A) is a newer tumor suppressor that binds to and stabilizes microtubules as well as induces M-phase cell cycle arrest. Several other proteins that interact with and stabilize microtubules also undergo mitotic phase phosphorylation to regulate microtubule dynamics and M-phase cell cycle progression. Currently, however, there is a paucity of information regarding the phosphorylation status of RASSF1A and its regulation during mitosis. In this study, for the first time, we demonstrate that Aurora-A is a RASSF1A kinase and, to the best of our knowledge, this is also the first study reporting the identification of a kinase for RASSF1A. We show that the mitotic kinase Aurora-A directly interacts with and phosphorylates RASSF1 and that RASSF1A is phosphorylated by Aurora-A during mitosis. These findings therefore link an important oncogenic mitotic kinase to regulate RASSF1A tumor suppressor. Aurora-A appears to phosphorylate RASSF1A at Threonine202 and/or Serine203 that reside within the known microtubule-binding domain of RASSF1A. Substitutions of these residues with glutamic acid at both positions, mimicking constitutive phosphorylation of RASSF1A, disrupt RASSF1A interactions with microtubules and abolish its ability to induce M-phase cell cycle arrest. Our results further demonstrate that Aurora-A overexpression also interferes with RASSF1A-mediated growth suppression. In view of our results, we propose that Aurora-A-mediated phosphorylation of RASSF1A is a novel mechanism that regulates the ability of this tumor suppressor to interact with microtubules and modulate M-phase cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17563743     DOI: 10.1038/sj.onc.1210575

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  41 in total

1.  Characterization of Human Homeodomain-interacting Protein Kinase 4 (HIPK4) as a Unique Member of the HIPK Family.

Authors:  Qin He; Jingxue Shi; Hong Sun; Jie An; Ying Huang; M Saeed Sheikh
Journal:  Mol Cell Pharmacol       Date:  2010

2.  Negative regulation of p53 by Ras superfamily protein RBEL1A.

Authors:  Ki Lui; Jie An; Joanne Montalbano; Jingxue Shi; Chad Corcoran; Qin He; Hong Sun; M Saeed Sheikh; Ying Huang
Journal:  J Cell Sci       Date:  2013-04-09       Impact factor: 5.285

3.  Cullin-4A·DNA damage-binding protein 1 E3 ligase complex targets tumor suppressor RASSF1A for degradation during mitosis.

Authors:  Lingyan Jiang; Rong Rong; M Saeed Sheikh; Ying Huang
Journal:  J Biol Chem       Date:  2011-01-04       Impact factor: 5.157

4.  Aurora-A phosphorylates Augmin complex component Hice1 protein at an N-terminal serine/threonine cluster to modulate its microtubule binding activity during spindle assembly.

Authors:  Connie Y Tsai; Bryan Ngo; Anjali Tapadia; Pang-Hung Hsu; Guikai Wu; Wen-Hwa Lee
Journal:  J Biol Chem       Date:  2011-06-24       Impact factor: 5.157

5.  PDRG1, a novel tumor marker for multiple malignancies that is selectively regulated by genotoxic stress.

Authors:  Lingyan Jiang; Xiuquan Luo; Jingxue Shi; Hong Sun; Qing Sun; M Saeed Sheikh; Ying Huang
Journal:  Cancer Biol Ther       Date:  2011-03-15       Impact factor: 4.742

Review 6.  Mitotic failures in cancer: Aurora B kinase and its potential role in the development of aneuploidy.

Authors:  Katalin Hegyi; Gábor Méhes
Journal:  Pathol Oncol Res       Date:  2012-07-29       Impact factor: 3.201

7.  USP7 and Daxx regulate mitosis progression and taxane sensitivity by affecting stability of Aurora-A kinase.

Authors:  S Giovinazzi; V M Morozov; M K Summers; W C Reinhold; A M Ishov
Journal:  Cell Death Differ       Date:  2013-01-25       Impact factor: 15.828

8.  Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II.

Authors:  Benjamin Stieglitz; Christine Bee; Daniel Schwarz; Ozkan Yildiz; Anna Moshnikova; Andrei Khokhlatchev; Christian Herrmann
Journal:  EMBO J       Date:  2008-07-03       Impact factor: 11.598

9.  Molecular markers of tumor progression in melanoma.

Authors:  Joshua Rother; Dan Jones
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

10.  Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway.

Authors:  Ya-Shih Tseng; Jenq-Chang Lee; Chi-Ying F Huang; Hsiao-Sheng Liu
Journal:  BMC Cancer       Date:  2009-12-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.